Globe Net Wireless Corp.
GNTW
Other OTC3.00
USD
+0.90
- -
Globe Net Wireless Corp.
GNTW
(Other OTC)
Recent
price
3.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Globe Net Wireless Corp. (GNTW) operates as a development-stage company focused on telecommunications, originally developing mobile enterprise software to enhance field service productivity for high-technology products through wireless platforms; following a reverse merger, it now functions under Stemtech Corporation, a global network marketing entity specializing in science-based stem cell nutrition products that support adult stem cell release, circulation, and migration for wellness. Core offerings include the RCM System for stem cell physiology support; branded supplements such as stemrelease3, StemFlo, MigraStem, and OraStem for oral health; skincare products like Cellect One Rapid Renew Stem Cell Peptide Night Cream launched in December 2022 and Cellect One Shield HOCL skin care mist introduced in January 2025; and upcoming StemPets pet supplements planned for April 2025. Products are marketed through independent business partners and direct-to-consumer channels across subsidiaries in the United States, Canada, Mexico, Ecuador, Malaysia, Taiwan, and other regions; the company targets wellness consumers via multi-level distribution without containing stem cells, relying instead on plant-based botanicals. Founded in 2009 and headquartered in Miramar, Florida, with current operations at 4851 Tamiami Trail North, Suite 200, Naples, Florida, the company underwent a pivotal reverse merger on August 19, 2021, with Stemtech Corporation (Delaware), acquiring its operations and resulting in a name change to Stemtech Corporation approved by FINRA on April 14, 2022, alongside a fiscal year-end shift to December; it trades on OTCQB as STEK post-recapitalization.